Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 17/20 | 0.65 |
| ▸ | CRBN | Q96SW2 | 17/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30859555 | 1.00 | DDB1 (0.65) | DDB1CRBNKDM4EMAPTTHRB | |
| SCHEMBL30257373 | 0.82 | DDB1 (0.62) | DDB1CRBNMAPTALDH1A1 | |
| SCHEMBL27039808 | 0.82 | DDB1 (0.62) | DDB1CRBNKDM4EMAPTTHRB | |
| SCHEMBL25631810 | 0.81 | DDB1 (0.60) | DDB1CRBNMAPT | |
| SCHEMBL23538658 | 0.81 | DDB1 (0.69) | DDB1CRBNKDM4EMAPTTHRB | |
| SCHEMBL21965415 | 0.81 | DDB1 (0.67) | DDB1CRBN | |
| SCHEMBL23538462 | 0.81 | DDB1 (0.77) | DDB1CRBNKDM4EMAPTTHRB | |
| SCHEMBL23539242 | 0.81 | DDB1 (0.77) | DDB1CRBNKDM4EMAPTTHRB | |
| SCHEMBL21965763 | 0.81 | DDB1 (0.77) | DDB1CRBNKDM4EMAPTTHRB | |
| SCHEMBL29946906 | 0.81 | DDB1 (0.77) | DDB1CRBNKDM4EMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024073475-A9 | CEREBLON LIGANDS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A/ SK LIFE SCIENCE LABS (US) | 2025-04-24 | — | — | WO | disclosed |
| WO-2024073475-A1 | CEREBLON LIGANDS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | disclosed |